Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc.（ARTV）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
artv · 股价预测 · 4 位分析师（近3月）· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 4 位华尔街分析师
Buy
4 位分析师
共识
评级分布
12 个月目标价
High
$40.00
Consensus
$37.50
+451.5% upside
Low
$35.00
Median: $37.5 · Last Close: $6.80
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$37.50
451.5% upside
High Target
$40
488.2%
Low Target
$35
414.7%
Current Price
$6.80
as of today
Based on analyst price targets, the ARTV stock price prediction for the next 12 months ranges from $35 to $40. The consensus ARTV price forecast of $37.50 implies 451.5% upside from the current price of $6.80.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $6.46 | ↓ 5.00% |
1-day model range: $6.37–$6.55. Peak: $6.55 (-5.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ARTV · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-12 | Needham | Maintains | Buy→Buy |
| 2026-05-11 | Wedbush | Maintains | Outperform→Outperform |
| 2026-05-11 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2026-05-08 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-04 | Needham | Maintains | Buy→Buy |
| 2026-03-11 | Needham | Maintains | Buy→Buy |
| 2025-11-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-17 | Wedbush | Maintains | Outperform→Outperform |
| 2025-10-17 | Needham | Maintains | Buy→Buy |
| 2025-05-15 | Needham | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Artiva Biotherapeutics, Inc. (ARTV) stock. Of the recent 17 rating actions, 0 were upgrades and 0 were downgrades. 4 analysts currently cover ARTV.
分析师推荐趋势
ARTV analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 5 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$0M
↓ 100.0% YoY
Revenue Next Year
$0M
EPS This Year
$-2.67
EPS Next Year
$-2.91
↑ 9.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast ARTV EPS of $-2.67 for the current fiscal year, based on estimates from 4 analysts. The ARTV revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ARTV 股价预测由两类独立数据源支撑：来自 4 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ARTV 的共识目标价为 $37.50（+451.5% 上行空间），分析师共识为 Buy。
ARTV 的短期预测（明日）为 $6.46（-5.00%）。
Artiva Biotherapeutics, Inc. 在 NASDAQ 上市，代码 ARTV。ARTV 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
ARTV 预测 · 8 个问题根据 4 位华尔街分析师，ARTV 的 12 个月平均目标价为 $37.50，最高 $40.00、最低 $35.00。若有图表，中位目标价可在上方查看。相对当前价 $6.80，隐含约 +451.5% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.